These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2010-022819-19 Efficacy, safety and tolerability of two weeks treatment with SIA capsules in acute bronchitis - A multi-centre, randomised, placebo-controlled, double-blind, parallel-group trial - 2011-05-29 due-trials
Not reported 2012-005288-29 A single-center randomized, active-controlled, observer-blinded, parallel group trial to evaluate the efficacy and safety of a topical dimeticone formulation (Loion®) compared to 10% saliclylic acid i... 2014-01-30 due-trials
Not reported Terminated 2013-004860-78 A randomised, active-controlled, observer-blind, non-inferiority study to investigate the efficacy, safety and tolerability of a local treatment with dimeticone-based pediculicides in head lice infest... 2015-02-23 due-trials
Completed, but no date 2016-004460-19 A multi-centre, randomized, placebo-controlled, double-blind trial to assess the efficacy and safety of nitroglycerin sublingual powder on walking distance in a scheduled forced titration design in pa... bad-data
Completed, but no date 2016-004635-20 A monocentric, randomized, controlled, investigator-blind trial to evaluate the efficacy and safety of an investigational medical device (PB790) in subjects with head lice. Monozentrische, randomis... bad-data
Not reported 2019-001717-17 A multi-centre, randomised, placebo-controlled, double-blind parallel-group trial to assess the efficacy and safety of SIA capsules in subjects with acute rhinosinusitis. Wirksamkeit und Verträglic... 2020-03-30 due-trials
Not reported 2020-003779-17 A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI) -COVARI- 2021-07-19 due-trials
Completed, report not yet due 2022-003478-22 A randomised, placebo-controlled, double-blind parallel-group trial to assess the efficacy and safety of PB432 in outpatients with COVID-19 induced acute respiratory infection - COVARI-2 study- ... 2024-04-18 not-yet-due